Table 4.

Variables related to high TP volume (≥ 1.43mm³)

	Univariate analysis			Multivariate analysis
	OR	95%CI	p value	OR	95%CI	P value
ACS	1.406	0.737–2.684	0.302
Prior MI	0.566	0.210–1.527	0.261
Dyslipidemia	0.710	0.346–1.454	0.349
LDL-C	1.755	1.029–2.995	0.039	0.596	0.245–1.446	0.252
HDL-C	0.174	0.036–0.828	0.028	1.436	0.159–13.006	0.748
Apo B/A1	1.043	1.023–1.064	< 0.001	1.041	1.007–1.076	0.019
WBC count	1.177	0.996–1.391	0.055
CRP	1.004	0.862–1.170	0.956
LVEF	0.997	0.960–1.036	0.892
Stent length	1.026	0.990–1.064	0.165
Stent diameter	1.533	0.776–3.030	0.218
Maximal dilatation pressure	1.012	0.927–1.106	0.789
Pre-intervention MLA	0.884	0.655–1.193	0.421
Plaque rupture	1.818	0.918–3.601	0.086
Plaque erosion	2.739	1.361–5.510	0.005	2.013	0.917–4.419	0.081
TCFA	6.818	2.758–16.854	< 0.001	3.647	1.315–10.114	0.013
Intracoronary thrombus	2.267	1.150–4.468	0.018	2.866	1.277–6.434	0.011

ACS acute coronary syndrome, TP tissue prolapse, MI myocardial infarction, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, WBC white blood cell, Apo apolipoprotein, CRP C-reaction protein, LVEF left ventricular ejection fraction, MLA minimal lumen area, TCFA thin-cap fibroatheroma